APA (7th ed.) Citation

Carlos Gonzalez-Juanatey, Tomas R. Vazquez-Rodriguez, Jose A. Miranda-Filloy, Ines Gomez-Acebo, Ana Testa, Carlos Garcia-Porrua, . . . Miguel A. González-Gay. (2012). Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy. Hindawi Limited.

Chicago Style (17th ed.) Citation

Carlos Gonzalez-Juanatey, Tomas R. Vazquez-Rodriguez, Jose A. Miranda-Filloy, Ines Gomez-Acebo, Ana Testa, Carlos Garcia-Porrua, Amalia Sanchez-Andrade, Javier Llorca, and Miguel A. González-Gay. Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function Without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy. Hindawi Limited, 2012.

MLA (9th ed.) Citation

Carlos Gonzalez-Juanatey, et al. Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function Without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy. Hindawi Limited, 2012.